TrialClinical and translational science2025

Quantifying Risk of Delayed QT Prolongation of Ipatasertib in Preclinical and Clinical Studies in Cancer Patients.

Victor Poon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.